DCPH - デシフィラ・ファ―マシュ―ティカルズ (Deciphera Pharmaceuticals Inc.)

DCPHのニュース

   H.C. Wainwright Stick to Their Buy Rating for Deciphera Pharmaceuticals By Investing.com  2021/08/04 10:26:39 Investing.com
H.C. Wainwright Stick to Their Buy Rating for Deciphera Pharmaceuticals
   Deciphera Pharmaceuticals EPS misses by $0.06, beats on revenue  2021/08/03 20:49:12 Seeking Alpha
   Is it time to Buy before this weeks earning report Deciphera Pharmaceuticals (NASDAQ:DCPH)  2021/08/03 12:51:00 Stock Market Daily
Earnings results for Deciphera Pharmaceuticals , Analyst Opinion on Deciphera Pharmaceuticals , Earnings and Valuation of (NASDAQ:DCPH), Stock market Insights & financial analysis, Best stock to invest, Investment Idea, The post Is it time to Buy before this weeks earning report Deciphera Pharmaceuticals (NASDAQ:DCPH) appeared first on .
   The Daily Biotech Pulse: ObsEva Surges On Out-Licensing Deal, EyeGate Appoints New CEO, 2 Positive Catalysts For Merck, Candel Therapeutics Debuts  2021/07/27 11:48:32 Benzinga
Here''s a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 26) Absci, CORP (NASDAQ: ABSI ) (IPOed Thursday) Arvinas, Inc. (NASDAQ: ARVN ) BioNTech SE (NASDAQ: BNTX ) ( disclosed plans to make mRNA vaccine for malaria by 2022) Cassava Sciences, Inc. (NASDAQ: SAVA ) (announced positive data for SavaDx, an investigational diagnostic/biomarker to detect Alzheimer''s disease with a simple blood test) Eli Lilly and Company (NYSE: LLY ) Moderna, Inc. (NASDAQ: MRNA ) Monte Rosa Therapeutics, Inc. (NASDAQ: GLUE ) NanoVibronix, Inc. (NASDAQ: NAOV ) (announced first shipment of its next generation pain management device, PainShield Plus) Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ) Sight Sciences, Inc. (NASDAQ: SGHT ) (IPOed July 15) Translate Bio, Inc. (NASDAQ: TBIO ) (moved on positive analyst action) Down In The Dumps (Biotech Stocks Hitting 52-week Lows July 26) 23andMe Holding Co. (NASDAQ: ME ) AbCellera Biologics Inc.
   Global Tyrosine Protein Kinase Lyn Market 2021 Future Set to Massive Growth with High CAGR value | Market Players: AB Science SA, Pfizer Inc., Boehringer Ingelheim GmbH, Deciphera Pharmaceuticals, LLC  2021/07/23 22:10:51 Jumbo News
The report on Global Tyrosine Protein Kinase Lyn Market has been provided by researchers for a detailed understanding of market performance over an estimated period of time set from 2021 to 2026. However, this report has introduced a brief overview to provide the reader with better information on this report. This brief description contains a []
   Deciphera Announces First Patient Treated in Phase 1 Study of DCC-3116 in Patients with Advanced or Metastatic Tumors with a Mutant RAS or RAF Gene  2021/06/30 20:01:00 Finanzen AT
Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a commercial-stage biopharmaceutical company developing innovative medicines to improve the lives of people with cancer, today announced dose administration for the first
   Deciphera Pharmaceuticals (NASDAQ-DCPH) Is In A Good Position To Deliver On Growth Plans  2021/06/24 06:57:17 Yahoo Finance
Deciphera Pharmaceuticals (NASDAQ:DCPH) Is In A Good Position To Deliver On Growth Plans Yahoo Finance
   Deciphera Pharmaceuticals posts data from cancer studies at ASCO21  2021/06/04 13:47:01 Seeking Alpha
   Deciphera Pharmaceuticals, Inc. to Present at Upcoming Investor Conferences  2021/05/27 00:00:00 BioSpace
Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) today announced that Steve Hoerter, President and Chief Executive Officer, will participate in fireside chats at the following investor conferences: Jefferies Virtual Healthcare Conference on June 3, 2021 at 1:30 PM ET JMP Securities Life Sciences Conference on June 16, 2021 at 4:00 PM ET
   Deciphera Pharmaceuticals (DCPH) Investor Presentation - Slideshow  2021/05/17 18:50:58 Seeking Alpha
   Deciphera Pharmaceuticals, Inc. to Present at the Barclays Global Healthcare Conference  2021/03/02 12:00:00 Business Wire
WALTHAM, Mass.--(BUSINESS WIRE)--Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) today announced that Steve Hoerter, President and Chief Executive Officer, will participate in a fireside chat at the Barclays Global Healthcare Conference on March 9, 2021 at 1:50 PM ET. The conference will be held in a virtual meeting format. A live webcast of the event will be available on the “Events and Presentations” page in the “Investors” section of the Company’s website at https://investors.deciphera.com/ne
   Deciphera Pharmaceuticals, Inc. to Present at the SVB Leerink 10th Annual Global Healthcare Conference  2021/02/18 12:00:00 Business Wire
WALTHAM, Mass.--(BUSINESS WIRE)--Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) today announced that Steve Hoerter, President and Chief Executive Officer, will participate in a fireside chat at the SVB Leerink 10th Annual Global Healthcare Conference on February 25, 2021 at 4:20 PM ET. The conference will be held in a virtual meeting format. A live webcast of the event will be available on the “Events and Presentations” page in the “Investors” section of the Company’s website at https://investo
   Deciphera Pharmaceuticals Provides Corporate Update and Highlights Key 2021 Corporate Milestones  2021/01/11 12:00:00 Business Wire
WALTHAM, Mass.--(BUSINESS WIRE)--Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH), a commercial-stage biopharmaceutical company developing innovative medicines to improve the lives of people with cancer, today provided a corporate update and highlighted key 2021 milestones in conjunction with its presentation at the 39th Annual J.P. Morgan Virtual Healthcare Conference. The Company will webcast its presentation today at 9:10 AM ET at https://investors.deciphera.com/news-events/events-presentations
   Deciphera Pharmaceuticals to Present at the 39th Annual J.P. Morgan Healthcare Conference  2021/01/05 12:23:00 Business Wire
WALTHAM, Mass.--(BUSINESS WIRE)--Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) today announced that Steve Hoerter, President and Chief Executive Officer, will present at the 39th Annual J.P. Morgan Healthcare Conference on Monday, January 11, 2021 at 9:10 AM ET. A live webcast of the event will be available on the “Events and Presentations” page in the “Investors” section of the Company’s website at https://investors.deciphera.com/news-events/events-presentations. A replay of the webcast will b
   Medison Pharma beschließt regionsübergreifende Vertriebspartnerschaft mit Deciphera Pharmaceuticals zur Vermarktung von QINLOCK® (Ripretinib)  2020/11/06 19:15:00 PR Newswire
PETACH TIKVA, Israel und WALTHAM, Massachusetts, 6. November 2020 /PRNewswire/ -- Medison Pharma ist ein weltweit führender Handelspartner für hochmoderne Therapien. Das Unternehmen hat heute seine exklusive Vertriebspartnerschaft mit Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH)…

calendar